Anti-LIV-1 / SLC39A6 Reference Antibody (Ladiratuzumab vedotin)

Product Name :
Anti-LIV-1 / SLC39A6 Reference Antibody (Ladiratuzumab vedotin)

synonym :

productDescription :
Ladiratuzumab vedotin is an ADC that combines a humanized anti-LIV-1 monoclonal antibody linked to a synthetic cytotoxic cell-disrupting agent, monomethyl auristatin E (MMAE)

molecularWeight :
146.96 kDa

endotoxin :
<0.001 EU/ug

purity :
>95% as determined by SDS-PAGE.

formulation :
100 mM Pro-Ac 20mM Arg pH 5.0

storage :
-80°C for 2 years under sterile conditions； -20°C for 1 year under sterile conditions；Avoid repeated freeze-thaw cycles.

reactivity :
Human, Mouse, Cynomolgus [US20160185858A1]

concentration :
4.56 mg/mL

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
LC3B Antibody
NLRP3 Antibody
PKA 2 beta (regulatory subunit)Antibody: PKA 2 beta (regulatory subunit)Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to PKA 2 beta (regulatory subunit). It can be used for WB,IP,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Ubiquitin Ligase- ubiquitin-ligase

Related Posts